141 related articles for article (PubMed ID: 3888536)
1. Second cancers following antineoplastic therapy.
Dorr FA; Coltman CA
Curr Probl Cancer; 1985 Feb; 9(2):1-43. PubMed ID: 3888536
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenicity of antineoplastic agents in man.
Rieche K
Cancer Treat Rev; 1984 Mar; 11(1):39-67. PubMed ID: 6375862
[TBL] [Abstract][Full Text] [Related]
3. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cadman EC; Capizzi RL; Bertino JR
Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
[TBL] [Abstract][Full Text] [Related]
4. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
5. Second neoplasms in Hodgkin's disease: current controversies.
Zarrabi MH; Rosner F
Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
[TBL] [Abstract][Full Text] [Related]
6. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
7. Second neoplasms following radiotherapy or chemotherapy for cancer.
Penn I
Am J Clin Oncol; 1982 Feb; 5(1):83-96. PubMed ID: 7081142
[TBL] [Abstract][Full Text] [Related]
8. Second malignancy complicating Hodgkin's disease.
Tawil E; Mercier JP
J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Petru E; Schmähl D
Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemia.
de Gramont A; Rioux E; Drolet Y; Delage JM
Cancer; 1985 Feb; 55(3):493-5. PubMed ID: 4038378
[TBL] [Abstract][Full Text] [Related]
11. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
12. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
[TBL] [Abstract][Full Text] [Related]
13. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
14. Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease.
Boivin JF; Hutchison GB
J Natl Cancer Inst; 1981 Oct; 67(4):751-60. PubMed ID: 6944544
[No Abstract] [Full Text] [Related]
15. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
[TBL] [Abstract][Full Text] [Related]
16. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
Br Med J; 1980 Jan; 280(6209):216-9. PubMed ID: 6775732
[TBL] [Abstract][Full Text] [Related]
18. Ten-year nodular sclerosis Hodgkin's disease and second malignancies.
Zulian GB; Mirimanoff RO
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):659-65. PubMed ID: 2714343
[TBL] [Abstract][Full Text] [Related]
19. Risk of new cancers in patients with Hodgkin's disease.
Arseneau JC; Canellos GP; Johnson R; DeVita VT
Cancer; 1977 Oct; 40(4 Suppl):1912-6. PubMed ID: 907993
[No Abstract] [Full Text] [Related]
20. Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
Gomez GA; Aggarwal KK; Han T
Cancer; 1982 Dec; 50(11):2285-8. PubMed ID: 7139526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
